Lista de obras - Federico Perosa - Dominio Público Uruguay

A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies

artículo científico publicado en 1986

Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma

artículo científico publicado en 2009

Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases.

artículo científico publicado en 1997

Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association

artículo científico publicado en 2018

Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin

artículo científico publicado en 2015

Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit

artículo científico publicado en 1994

Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections

artículo científico publicado en 2011

Antiphospholipids Syndrome Complicated by a Systemic Capillary Leak-Like Syndrome Treated With Steroids and Intravenous Immunoglobulins: A Case Report

artículo científico publicado en 2016

Assessment of safety and the immune response to the CD4 "internal antigen" mouse anti-idiotypic Mab 16D7 in four patients with SLE

artículo científico publicado en 2002

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis

artículo científico publicado en 2013

Autoantibodies to intracellular antigens: generation and pathogenetic role.

artículo científico publicado en 2011

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

artículo científico publicado en 2003

Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression

artículo científico publicado en 2002

Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease

artículo científico publicado en 2005

CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases

artículo científico publicado en 2005

CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases

artículo científico publicado en 2016

CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading

scientific article published in 2019

CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.

artículo científico publicado en 2010

CD20: a target antigen for immunotherapy of autoimmune diseases

artículo científico publicado en 2005

Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report

artículo científico publicado en 2004

Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis

artículo científico publicado en 2013

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis

artículo científico publicado en 2015

Cloning and chromosomal localization of a cDNA encoding a mitochondrial porin from Drosophila melanogaster

artículo científico publicado en 1996

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice

article

Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile

artículo científico publicado en 1998

Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study

scientific article published on 02 November 2019

Extra-articular manifestations of rheumatoid arthritis: An update

artículo científico

Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor

artículo científico publicado en 2005

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis

artículo científico publicado en 2018

Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies

artículo científico publicado en 1994

Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysis

artículo científico publicado en 2001

Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope

artículo científico publicado en 2004

Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy

artículo científico publicado en 2007

Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody

artículo científico publicado en 1991

Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma

artículo científico publicado en 1999

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphos

artículo científico publicado en 2017

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

article

MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells

artículo científico publicado en 2013

Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort

artículo científico publicado en 2018

Monoclonal antibodies in the immunotherapy of autoimmune diseases.

artículo científico publicado en 2001

New therapies in multiple myeloma.

artículo científico publicado en 2007

Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders

artículo científico publicado en 2018

Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort

scientific article published on 01 July 2019

Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate

artículo científico publicado en 1990

Raynaud's phenomenon: from molecular pathogenesis to therapy

artículo científico publicado en 2014

Rheumatic disorders as paraneoplastic syndromes

artículo científico publicado en 2008

SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment

scientific article published on 10 May 2020

Serological methods to detect anti-idiotypic antibodies

artículo científico publicado en 1989

Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype

artículo científico publicado en 1999

Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature

artículo científico publicado en 2013

Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma

artículo científico publicado en 2003

Soluble CD4 and commercial immunoglobulin

scientific article published on 01 June 1994

Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count

artículo científico publicado en 2008

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study

scientific article published on 03 September 2019

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study

artículo científico publicado en 2017

Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease

artículo científico publicado en 2016

Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens

artículo científico publicado en 1987

Syngeneic antiidiotypic antisera to murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies

artículo científico publicado en 1987

Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA-DR,DP monoclonal antibody CR11-462

artículo científico publicado en 1988

The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant

artículo científico publicado en 1997

The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3).

artículo científico publicado en 2010

Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes

artículo científico publicado en 2009

Vasculitides: Proposal for an integrated nomenclature

artículo científico publicado en 2015

[Anti-idiotypic antibodies in therapy: current status and prospects]

artículo científico publicado en 1989

Lista de obras de Federico Perosa

A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies

Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma

Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases.

Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association

Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin

Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit

Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections

Antiphospholipids Syndrome Complicated by a Systemic Capillary Leak-Like Syndrome Treated With Steroids and Intravenous Immunoglobulins: A Case Report

Assessment of safety and the immune response to the CD4 "internal antigen" mouse anti-idiotypic Mab 16D7 in four patients with SLE

Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis

Autoantibodies to intracellular antigens: generation and pathogenetic role.

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression

Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease

CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases

CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases

CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading

CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.

CD20: a target antigen for immunotherapy of autoimmune diseases

Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report

Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis

Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis

Cloning and chromosomal localization of a cDNA encoding a mitochondrial porin from Drosophila melanogaster

Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black/New Zealand white) F1 mice

Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile

Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study

Extra-articular manifestations of rheumatoid arthritis: An update

Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis

Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies

Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysis

Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope

Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy

Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody

Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphos

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells

Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort

Monoclonal antibodies in the immunotherapy of autoimmune diseases.

New therapies in multiple myeloma.

Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders

Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort

Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate

Raynaud's phenomenon: from molecular pathogenesis to therapy

Rheumatic disorders as paraneoplastic syndromes

SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment

Serological methods to detect anti-idiotypic antibodies

Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype

Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature

Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma

Soluble CD4 and commercial immunoglobulin

Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study

Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease

Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens

Syngeneic antiidiotypic antisera to murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies

Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA-DR,DP monoclonal antibody CR11-462

The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant

The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3).

Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes

Vasculitides: Proposal for an integrated nomenclature

[Anti-idiotypic antibodies in therapy: current status and prospects]